4.6 Review

Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: a Systematic Review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

Nicholas McGranahan et al.

SCIENCE (2016)

Article Medicine, Research & Experimental

T cell Bim levels reflect responses to anti-PD-1 cancer therapy

Roxana S. Dronca et al.

JCI INSIGHT (2016)

Article Oncology

Prognostic score for patients with advanced melanoma treated with ipilimumab

Stefan Diem et al.

EUROPEAN JOURNAL OF CANCER (2015)

Article Medicine, General & Internal

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

Emanuela Romano et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Multidisciplinary Sciences

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Eliezer M. Van Allen et al.

SCIENCE (2015)

Article Oncology

Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies

Douglas B. Johnson et al.

CANCER IMMUNOLOGY RESEARCH (2015)

Article Oncology

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

Sander Kelderman et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)

Article Oncology

Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab

Yvonne Saenger et al.

CLINICAL CANCER RESEARCH (2014)

Article Oncology

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

Lidia Robert et al.

CLINICAL CANCER RESEARCH (2014)

Article Multidisciplinary Sciences

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh et al.

NATURE (2014)

Article Medicine, General & Internal

Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanoma

Marliese Alexander et al.

MEDICAL JOURNAL OF AUSTRALIA (2014)

Article Medicine, General & Internal

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Alexandra Snyder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Multidisciplinary Sciences

Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab

F. Javier Ibarrondo et al.

PLOS ONE (2013)

Article Oncology

An immune-active tumor microenvironment favors clinical response to ipilimumab

Rui-Ru Ji et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)

Article Medicine, Research & Experimental

Biomarkers on melanoma patient T Cells associated with ipilimumab treatment

Wenshi Wang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)

Article Medicine, General & Internal

Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer

Suzanne L. Topalian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Jianda Yuan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)